EPC director granted 7,817 restricted stock units

Edgewell Personal Care director Stephanie Stahl reported a new equity grant.

Rhea-AI Filing Summary

Edgewell Personal Care director Stephanie Stahl reported a new equity grant. On February 5, 2026, she acquired 7,817 restricted stock equivalents at a price of $0 per unit. These are derivative securities that track the value of Edgewell common stock.

The restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders, unless Stahl elects to defer conversion until her service on Edgewell’s Board of Directors ends. After this grant, she beneficially owned 7,817 derivative units directly.

Insider Trade Summary

Grant/Award: 7,817 shares

Grant/Award 1 txn

Insider Stahl Stephanie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Equivalents 2-5-2026	7,817	$0.00	$0.00

Holdings After Transaction: Restricted Stock Equivalents 2-5-2026 — 7,817 contracts (Direct)

Footnotes (1)

1. F1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EPC director Stephanie Stahl report on this Form 4?

Stephanie Stahl reported receiving 7,817 restricted stock equivalents on February 5, 2026. These equity awards were granted at a price of $0 per unit and are tied to Edgewell common stock, reflecting a form of stock-based director compensation rather than an open-market purchase.

How many Edgewell (EPC) restricted stock equivalents did Stephanie Stahl receive?

Stephanie Stahl received 7,817 restricted stock equivalents linked to Edgewell common stock. This entire amount was acquired in a single transaction and represents her beneficial holdings of these derivative securities following the grant, according to the reported Form 4 details.

At what price were the EPC restricted stock equivalents granted to Stephanie Stahl?

The restricted stock equivalents were granted at a price of $0 per unit. This indicates they were awarded as compensation rather than purchased, giving the director exposure to Edgewell’s common stock value without an upfront cash outlay for the units themselves.

When do Stephanie Stahl’s EPC restricted stock equivalents convert into common shares?

The restricted stock equivalents convert into Edgewell common shares on the day preceding the next annual shareholder meeting. However, Stephanie Stahl can elect to defer this conversion, in which case it would occur upon the end of her service on the Board of Directors.

How many derivative securities does Stephanie Stahl beneficially own after this EPC transaction?

After the reported transaction, Stephanie Stahl beneficially owns 7,817 derivative securities, all in the form of restricted stock equivalents. The filing indicates these holdings are directly owned and tied to future conversion into Edgewell Personal Care common stock under the plan’s terms.

Is Stephanie Stahl’s EPC Form 4 transaction a purchase or an equity award?

The transaction reflects an equity award of restricted stock equivalents, not an open-market share purchase. The units were granted at $0 per unit as part of director compensation, and they will convert into Edgewell common stock under specified timing conditions described in the footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 10:48 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stahl Stephanie

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.